CA
BLUE

Crewe Advisors’s bluebird bio BLUE Stock Holding History

Crewe Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15
Closed -$29K – 229
2018
Q3 		$29K Sell
15
-3
-17% -$6.2K 0.02% 150
2018
Q2 		$36K Buy
18
+1
+6% +$2.28K 0.03% 142
2018
Q1 		$38K Buy
17
+2
+13% +$5.09K 0.04% 133
2017
Q4 		$36K Buy
+15
New +$30.5K 0.04% 142

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crewe Advisors's BLUE Position: Q4 2018 in Review

Crewe Advisors sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 15 shares — an estimated $29K sold.

Crewe Advisors first reported a position in BLUE in Q4 2017 and held it in 4 quarters. The position peaked at $38K in Q1 2018. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Crewe Advisors reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Crewe Advisors sold 15 bluebird bio shares in Q4 2018, an estimated $29K.
  • Crewe Advisors first reported a position in bluebird bio in Q4 2017 and held it in 4 quarters.
  • Crewe Advisors's bluebird bio position peaked at $38K in Q1 2018.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Crewe Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.